Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Oxytocin measurement |
Has measured component (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
|
Accidental oxytocin poisoning |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
|
Intentional oxytocin poisoning |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
|
intoxication par l'oxytocine d'intention indéterminée |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
1 |
Fetal oxytocin stress test |
Direct substance |
False |
Oxytocin |
Inferred relationship |
Some |
|
Oxytocin measurement |
Component |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing oxytocin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Poisoning by oxytocin |
Causative agent (attribute) |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Oxytocic hormone adverse reaction |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
|
Oxytocin adverse reaction |
Causative agent (attribute) |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Oxytocin and ergometrine adverse reaction |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
1 |
Allergy to oxytocin (finding) |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
|
maléate d'ergométrine et oxytocine 500 microgrammes/5 unités/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytocin |
Inferred relationship |
Some |
|
Oxytocin 5units/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytocin |
Inferred relationship |
Some |
|
Oxytocin 10units/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytocin |
Inferred relationship |
Some |
|
Product containing ergometrine and oxytocin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Oxytocin 10unt infusion solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytocin |
Inferred relationship |
Some |
|
Fetal oxytocin stress test (procedure) |
Direct substance |
False |
Oxytocin |
Inferred relationship |
Some |
1 |
Adverse reaction to oxytocic agents |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
|
Adverse reaction to oxytocic agent NOS |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
|
Accidental oxytocin poisoning |
Causative agent (attribute) |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Intentional oxytocin poisoning |
Causative agent (attribute) |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Allergy to oxytocin and ergometrine |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
|
Oxytocin 10units/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytocin |
Inferred relationship |
Some |
|
Fetal oxytocin stress test (procedure) |
Direct substance |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing oxytocin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing oxytocin in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Oxytocin 10units/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytocin |
Inferred relationship |
Some |
|
Allergy to oxytocin (finding) |
Causative agent (attribute) |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Allergy to oxytocin and ergometrine |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
2 |
Allergy to oxytocin and ergometrine |
Causative agent (attribute) |
False |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing precisely ergometrine maleate 500 microgram/1 milliliter and oxytocin 5 unit/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Oxytocin |
Inferred relationship |
Some |
2 |
Product containing precisely ergometrine maleate 500 microgram/1 milliliter and oxytocin 5 unit/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxytocin |
Inferred relationship |
Some |
2 |
Product containing precisely oxytocin 10 unit/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing precisely oxytocin 10 unit/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing precisely oxytocin 5 unit/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing precisely oxytocin 5 unit/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing ergometrine and oxytocin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Ergometrine and oxytocin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing only oxytocin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing only oxytocin in nasal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing only oxytocin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Ergometrine and oxytocin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing precisely oxytocin 10 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing precisely oxytocin 10 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Oxytocin 5 unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Oxytocin 5 unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing precisely ergometrine maleate 500 microgram/1 milliliter and oxytocin 5 unit/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Product containing precisely ergometrine maleate 500 microgram/1 milliliter and oxytocin 5 unit/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Augmentation of labor using oxytocin |
Direct substance |
False |
Oxytocin |
Inferred relationship |
Some |
1 |
Administration of ergometrine and oxytocin |
Direct substance |
True |
Oxytocin |
Inferred relationship |
Some |
1 |
Augmentation of labor using oxytocin |
Direct substance |
True |
Oxytocin |
Inferred relationship |
Some |
2 |
Oxytocin induction of labour |
Direct substance |
True |
Oxytocin |
Inferred relationship |
Some |
1 |